Inhibitory effects of dobutamine on human gastric adenocarcinoma

doi:10.3748/wjg.v20.i45.17092

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 45

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6105)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

351

WORD

289

HTML

3500

Figures (1-5)

162

Sum=4302

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

898

Download

905

Sum=1803

Dec 7, 2014 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Research Report

World J Gastroenterol. Dec 7, 2014; 20(45): 17092-17099
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17092

Full Size Figure Download Figure

Figure 2 Dobutamine inhibits SGC-7901 cell migration. A: After treatment with 30 μmol/L dobutamine for 24 h, the number of migrated cells was reduced; B: Number of migrated cells was increased in the control group.

Citation: Zheng HX, Wu LN, Xiao H, Du Q, Liang JF. Inhibitory effects of dobutamine on human gastric adenocarcinoma. World J Gastroenterol 2014; 20(45): 17092-17099
URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17092.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17092